Age-specific vulnerability and high prevalence of delirium in pediatric intensive care based on a prospective cohort

AbdulRahman AlDaithan1,2, Naila Shaheen3,4, Eidah Alahmari3,5

  • 1King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. dr.a.aldaithan@gmail.com.

Scientific Reports
|December 29, 2024
PubMed

Insights

Pediatric delirium is common in intensive care units, affecting nearly 70% of children. Infants and those with respiratory issues are most vulnerable, with opioid use a significant risk factor.

Area of Science:

  • Pediatric critical care medicine
  • Neuropsychiatry
  • Epidemiology

Background:

  • Delirium significantly impacts children in Pediatric Intensive Care Units (PICUs), causing longer hospital stays and increased mortality.
  • Understanding the burden and risk factors of pediatric delirium is crucial for improving patient outcomes.
  • This study addresses the knowledge gap regarding delirium in critically ill children.

Purpose of the Study:

  • To investigate the prevalence and characteristics of delirium in a tertiary PICU.
  • To identify risk factors and potential therapeutic targets for pediatric delirium.
  • To analyze the association between delirium and clinical outcomes in critically ill children.

Main Methods:

  • Prospective cohort study of 890 children admitted to a PICU.
  • Screening for delirium every 12 hours using the Cornell Assessment of Pediatric Delirium (CAPD).
  • Analysis of demographics, comorbidities, medications, interventions, and clinical outcomes to identify delirium associations.

Main Results:

  • High prevalence of delirium (69.4%), with infants disproportionately affected (33.5% of cases).
  • Respiratory diagnoses (78.6%) significantly associated with delirium; opioid use increased risk by 45.2%.
  • Delirium linked to longer PICU stays and all 20 mortalities; 97.6% of children with withdrawal syndrome had delirium.

Conclusions:

  • Pediatric delirium is highly prevalent in PICUs, with infants and those with respiratory diagnoses being particularly vulnerable.
  • Opioid use and withdrawal syndrome are significant risk factors for delirium in critically ill children.
  • Further research is needed to develop targeted interventions for preventing and managing pediatric delirium.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...